HealthEquity (HQY)
(Delayed Data from NSDQ)
$55.10 USD
-1.02 (-1.82%)
Updated May 26, 2023 04:00 PM ET
After-Market: $55.07 -0.03 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Income Statements
Fiscal Year end for HealthEquity, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | 1/31/19 | |
---|---|---|---|---|---|
Sales | 862 | 757 | 734 | 532 | 287 |
Cost Of Goods | 372 | 333 | 318 | 206 | 106 |
Gross Profit | 490 | 424 | 415 | 326 | 181 |
Selling & Adminstrative & Depr. & Amort Expenses | 481 | 448 | 381 | 249 | 104 |
Income After Depreciation & Amortization | 9 | -24 | 34 | 77 | 78 |
Non-Operating Income | 1 | -6 | 5 | -9 | -2 |
Interest Expense | 48 | 37 | 35 | 25 | 0 |
Pretax Income | -38 | -67 | 4 | 43 | 76 |
Income Taxes | -12 | -22 | -5 | 3 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -26 | -44 | 9 | 40 | 74 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -26 | -44 | 9 | 40 | 74 |
Depreciation Footnote | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | 1/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 174 | 117 | 155 | 132 | 96 |
Depreciation & Amortization (Cash Flow) | 164 | 142 | 121 | 55 | 18 |
Income After Depreciation & Amortization | 9 | -24 | 34 | 77 | 78 |
Earnings Per Share Data | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | 1/31/19 |
---|---|---|---|---|---|
Average Shares | 84.44 | 83.13 | 75.68 | 68.45 | 63.37 |
Diluted EPS Before Non-Recurring Items | 0.77 | 0.82 | 1.22 | 1.38 | 0.95 |
Diluted Net EPS (GAAP) | -0.31 | -0.53 | 0.12 | 0.58 | 1.17 |
Fiscal Year end for HealthEquity, Inc falls in the month of January .
All items in Millions except EPS data.
4/30/23 | 1/31/23 | 10/31/22 | 7/31/22 | 4/30/22 | |
---|---|---|---|---|---|
Sales | NA | 233.84 | 216.09 | 206.14 | 205.68 |
Cost Of Goods | NA | 99.59 | 89.23 | 88.33 | 94.51 |
Gross Profit | NA | 134.25 | 126.86 | 117.81 | 111.17 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 121.03 | 121.32 | 120.22 | 118.46 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 13.22 | 5.54 | -2.41 | -7.29 |
Non-Operating Income | NA | 1.10 | 0.44 | 0.03 | -0.30 |
Interest Expense | NA | 14.31 | 12.17 | 11.49 | 10.46 |
Pretax Income | NA | 0.01 | -6.18 | -13.87 | -18.05 |
Income Taxes | NA | 0.22 | -4.54 | -3.22 | -4.41 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.21 | -1.64 | -10.65 | -13.64 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.21 | -1.64 | -10.65 | -13.64 |
Earnings Per Share Data | 4/30/23 | 1/31/23 | 10/31/22 | 7/31/22 | 4/30/22 |
---|---|---|---|---|---|
Average Shares | NA | 84.72 | 84.57 | 84.44 | 84.02 |
Diluted EPS Before Non-Recurring Items | NA | 0.26 | 0.21 | 0.16 | 0.15 |
Diluted Net EPS (GAAP) | NA | 0.00 | -0.02 | -0.13 | -0.16 |